Browsing by Author Brunetto, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 4 to 7 of 7 < previous 
TitleAuthor(s)Issue DateViews
 
HBV DNA AND HBSAG LEVELS AT 24 WEEKS OFF-TREATMENT PREDICT CLINICAL RELAPSE AND HBSAG LOSS IN HBEAG NEGATIVE PATIENTS WHO DISCONTINUED ANTIVIRAL THERAPY
Journal:Gastroenterology
Sonneveld, MJChiu, S-MPark, JYBrakenhoff, SMKaewdech, ASeto, WKTanaka, YCarey, IPapatheodoridi, MColombatto, PVan Bömmel, FJanssen, HLBerg, TZoulim, FAhn, SHDalekos, GNErler, NSBrunetto, MWedemeyer, HCornberg, MYuen, MFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GChen, C-HMaasoumy, B
26-Sep-2023
 
Lower Pre-Treatment HBV DNA Levels Are Associated With Better Off-Treatment Outcomes After Nucleo(S)Tide Analogue Withdrawal In Patients With Chronic Hepatitis B
Proceeding/Conference:Hepatology
Sonneveld, MJChiu, SMPark, JYBrakenhoff, SKaewdech, ASeto, WKTanaka, YCarey, IPapatheodoridi, MColombatto, PVan Bommel, FBerg, TZoulim, FAhn, SHDalekos, GNErler, NSBrunetto, MWedemeyer, HCornberg, MYuen, MFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GVChen, CHMaasoumy, B
31-Oct-2022
 
Safety and efficacy at 1 year after switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in chronic HBV patients with risk factors for TDF use
Proceeding/Conference:Journal of Hepatology
Gane, ESeto, WKWJanssen, HCarantu, FAKim, HJAbdurakhmanov, DNishiguchi, SAndrzej, HBae, HMo, SSuri, VGaggar, AFlaherty, JFKao, JHBrunetto, MFerret, MB
2018
88
 
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Journal:The Lancet Gastroenterology & Hepatology
Buti, MGane, ESeto, WKWChan, HLChuang, WLStepanova, THui, AJLim, YSMehta, RJanssen, HAcharya, SKFlaherty, JMassetto, BCathcart, ALKim, KGaggar, ASubramanian, GMMcHutchison, JPan, CBrunetto, MIzumi, NMarcellin, P
2016
Showing results 4 to 7 of 7 < previous